Related references
Note: Only part of the references are listed.Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China
Wei Jing et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis
Junjie Ding et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti
Kathleen F. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2019)
The neurocritical care of tuberculous meningitis
Joseph Donovan et al.
LANCET NEUROLOGY (2019)
Key considerations in the pharmacotherapy of tuberculous meningitis
Sean Wasserman et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis
Lan Wen et al.
JOURNAL OF NEUROLOGY (2019)
Intensified antibiotic treatment of tuberculosis meningitis
Fiona V. Cresswell et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?
Ilaria Motta et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update
Oliver D. Mrowczynski et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii
Sarunyou Chusri et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Magnetic resonance imaging characteristics and treatment aspects of ventricular tuberculosis in adult patients
Duo Li et al.
ACTA RADIOLOGICA (2017)
Clinical features, long-term clinical outcomes, and prognostic factors of tuberculous meningitis in West China: a multivariate analysis of 154 adults
Kunyi Li et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral Infarction
Yuko Nakatani et al.
INTERNAL MEDICINE (2017)
Tuberculous meningitis
Robert J. Wilkinson et al.
NATURE REVIEWS NEUROLOGY (2017)
Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: matched cohort study
B. Shofty et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Isoniazid metabolism and hepatotoxicity
Pengcheng Wang et al.
ACTA PHARMACEUTICA SINICA B (2016)
Cerebral infarction and tuberculoma in central nervous system tuberculosis: frequency and prognostic implications
Mohammad Wasay et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy
Junichi Azuma et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Tuberculous meningitis: more questions, still too few answers
Guy E. Thwaites et al.
LANCET NEUROLOGY (2013)
Effects of the implantation of Ommaya reservoir in children with tuberculous meningitis hydrocephalus: a preliminary study
Jian Lin et al.
CHILDS NERVOUS SYSTEM (2012)
Treatment Outcomes of Isoniazid-Resistant Tuberculosis Patients, Western Cape Province, South Africa
Karen R. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2011)
Tuberculous meningitis: a uniform case definition for use in clinical research
Suzaan Marais et al.
LANCET INFECTIOUS DISEASES (2010)
Improving the role of intraventricular antimicrobial agents in the management of meningitis
Wendy C. Ziai et al.
CURRENT OPINION IN NEUROLOGY (2009)
British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children
Guy Thwaites et al.
JOURNAL OF INFECTION (2009)
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
DJ Begley
PHARMACOLOGY & THERAPEUTICS (2004)
Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin:: Case report
SE Berning et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
